Summary for Tradename: CEDAX
Clinical Trials for: CEDAX
Short-term Antibiotic Therapy for Pyelonephritis in Childhood
Status: Terminated Condition: Pyelonephritis
Patients Response to Early Switch To Oral:Osteomyelitis Study
Status: Not yet recruiting Condition: Osteomyelitis
Multicenter Study Comparing Morbidity and Quality of Life Associated in the Treatment by Surgical Resection and the Conservative Treatment, After Favorable Evolution of Purulent Peritonitis That Originates From Diverticulitis Treated by Mini-invasive Surgery
Status: Recruiting Condition: Peritonitis; Diverticulitis
Phase 3 Study With Carfilzomib and Dexamethasone Versus Velcade and Dexamethasone for Relapsed Multiple Myeloma Patients
Status: Active, not recruiting Condition: Multiple Myeloma
Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006
Status: Terminated Condition: Alzheimer´s Disease
Controlled Trial of Deep Brain Stimulation in Early Patients With Parkinson's Disease
Status: Active, not recruiting Condition: Parkinson Disease
Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease
Status: Completed Condition: Alzheimer's Disease
Esophageal High Resolution Manometry and Dysphagia
Status: Completed Condition: Dysphagia
Reirradiation and Erbitux in the HNSCC
Status: Recruiting Condition: Head Neck Cancer Squamous Cell.
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
Status: Completed Condition: Occult Primary
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|CAPSULE;ORAL||050685||Dec 20, 1995||RX||Yes||<disabled>||<disabled>|
|FOR SUSPENSION;ORAL||050686||Dec 20, 1995||DISCN||No||5,599,557||<disabled>||Y||<disabled>|
|FOR SUSPENSION;ORAL||050686||Dec 20, 1995||RX||Yes||5,599,557||<disabled>||Y||<disabled>|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639